Daniel Markowitz
Stock Analyst at Evercore ISI Group
(3.66)
# 803
Out of 5,046 analysts
17
Total ratings
66.67%
Success rate
5.57%
Average return
Main Sectors:
Stocks Rated by Daniel Markowitz
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Outperform | $68 → $90 | $93.02 | -3.25% | 2 | Oct 30, 2025 | |
| RMBS Rambus | Maintains: Outperform | $114 → $126 | $102.84 | +22.52% | 2 | Oct 28, 2025 | |
| WST West Pharmaceutical Services | Maintains: Outperform | $350 → $390 | $282.07 | +38.26% | 3 | Oct 23, 2025 | |
| TECH Bio-Techne | Maintains: Outperform | $60 → $72 | $62.57 | +15.07% | 2 | Oct 7, 2025 | |
| RGEN Repligen | Maintains: Outperform | $155 → $175 | $149.06 | +17.40% | 4 | Oct 7, 2025 | |
| INSP Inspire Medical Systems | Maintains: Outperform | $150 → $125 | $72.08 | +73.42% | 2 | Oct 7, 2025 | |
| TMDX TransMedics Group | Initiates: Outperform | $155 | $131.54 | +17.83% | 1 | Sep 16, 2025 | |
| NTRA Natera | Initiates: Outperform | $170 | $198.93 | -14.54% | 1 | Jul 28, 2025 |
Guardant Health
Oct 30, 2025
Maintains: Outperform
Price Target: $68 → $90
Current: $93.02
Upside: -3.25%
Rambus
Oct 28, 2025
Maintains: Outperform
Price Target: $114 → $126
Current: $102.84
Upside: +22.52%
West Pharmaceutical Services
Oct 23, 2025
Maintains: Outperform
Price Target: $350 → $390
Current: $282.07
Upside: +38.26%
Bio-Techne
Oct 7, 2025
Maintains: Outperform
Price Target: $60 → $72
Current: $62.57
Upside: +15.07%
Repligen
Oct 7, 2025
Maintains: Outperform
Price Target: $155 → $175
Current: $149.06
Upside: +17.40%
Inspire Medical Systems
Oct 7, 2025
Maintains: Outperform
Price Target: $150 → $125
Current: $72.08
Upside: +73.42%
TransMedics Group
Sep 16, 2025
Initiates: Outperform
Price Target: $155
Current: $131.54
Upside: +17.83%
Natera
Jul 28, 2025
Initiates: Outperform
Price Target: $170
Current: $198.93
Upside: -14.54%